As of 2026-10-25, the Intrinsic Value of Medicenna Therapeutics Corp (MDNA.TO) is -1.01 CAD. This MDNA.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.43 CAD, the upside of Medicenna Therapeutics Corp is -336.61%.
Based on its market price of 0.43 CAD and our intrinsic valuation, Medicenna Therapeutics Corp (MDNA.TO) is overvalued by 336.61%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.01 - -1.01 | -1.01 | -336.61% |
| P/E | 0.42 - 0.42 | 0.42 | -0.6% |
| DDM - Stable | (1.54) - (5.85) | (3.69) | -969.0% |
| DDM - Multi | (1.33) - (4.12) | (2.04) | -579.1% |
| Market Cap (mil) | 39.23 |
| Beta | 1.44 |
| Outstanding shares (mil) | 92.30 |
| Enterprise Value (mil) | 33.64 |
| Market risk premium | 5.10% |
| Cost of Equity | 10.12% |
| Cost of Debt | 5.00% |
| WACC | 10.10% |